glp2 tirzepatide GLP-2 T Tirzepatide 30mg | Illuminated Peptides

The conversion chart between semaglutide and tirzepatide helps patients and providers navigate this transition if it becomes necessary

In practice, this means tirzepatide often produces slightly less nausea at equivalent dose escalation points (thanks to the GIP component), potentially stronger appetite suppression once doses reach therapeutic levels, and additional metabolic benefits that semaglutide does not provide

It effectively reduces hunger and extends feelings of fullness, helping to cut down on calorie consumption

Common day 2-3 experiences include feeling full after eating much less than usual, mild to moderate nausea especially after fatty or heavy foods, some people report diarrhea while others experience constipation (it can go either direction), fatigue that feels like you did not sleep enough even though you did, and mild headaches that may be related to reduced food intake or dehydration

There are no hidden-fees and insurance is not required

Our goal is to support you every step of the way, ensuring that you achieve and maintain your desired weight and health goals